Pharma Market Access in Israel.
your product. our efforts.
Final date for submissions is March 1st, each year. If you consider applying – NOW is the time. CONTACT US FOR FREE CONSULTATION
Our services
Products’ Registration
Our Regulatory team includes 2 pharmacists and 1 medical writer with vast knowledge of the regulatory arena in Israel. We offer active support along registration process, including:
• Preparation of all required documents (in Hebrew)
• Strategic support for dossier preparation
• Submission to regulatory authorities
• Close contact with regulatory authorities
• Follow-up and solutions for obstacles within the process
Market access
Our Market Access team includes 2 market access experts. Due to vast experience with market access in Israel and close contacts with decision’s makers, we are able to offer:
• Market access dossier preparation
• Active support with submission process
• Full support for strategic plan
• Detailed working plan along reimbursement process
• Relevant KOLs mapping
• Setting and participation in meeting with KOLs, HMOs & MoH decision makers
• Pricing schemes
• Market intelligence
• Mock Committee – unique process in which products are presented to key ex-committee members, enabling capturing strategy and key obstacles as viewed by the reimbursement committee
Medical Affairs
Those activities include KOLs mapping, advisory boards and 1:1 meeting with 1st tier KOLs. We do not only advise what activities to be conducted but also participate in those meetings, followed by strategic support based on the outcomes.
Clinical Trials
We offer guidance to sites’ selection, active support with the full regulatory process including compassionate use/early access/NPP activities. The captured data is used (when required) to support the reimbursement process and we actively present the data to HMOs and MoH.
Market Intelligence
Due to close contacts with key positions with HMOs and medical associations, we are able to provide real-time Market Intelligence re competitors, perception on existing/upcoming products, crisis resolution and strategic decisions.
Market Analysis
2 analysists within our team, are offering precise analysis of therapeutic areas, patients’ number, market share, competitors, ongoing clinical trials and KOLs perceptions on relevant products
PR
2 members of the team are recognized experts with Pharma PR in Israel’s market, familiar with PR regulation according to MoH (public campaigns are to receive prior approval by regulatory authorities), timely set activities oriented to support the different stages of the reimbursement process.
Lobbying
In-house team of lobby experts, offering vast array of activities with relevant decision makers, PAGs (Patient Association Group) and relevant Medical Associations.
Big Data Analysis
Following Covid-19 experience, Israel is well recognized as a reliable source of Big Data. Israeli HMOs have electronical records of all their patients, including data from the community clinics, outpatients’ clinics and hospitalizations. For Example, Clalit HMO is the owner of the second WW largest database, second only to Kaizer Permanente; Maccabi HMOs has a database of ~2.5 million patients. These resources, which are accessible, offer a vast area for HEOR (Heath Economic and Outcome Research) projects.
Distribution & Marketing
Marketing in Israel is largely dependant on the reimbursement status of the product. IMS IL has vast experience with obtaining reimbursement license, KOLs mapping, market analysis and successful marketing of products. We offer services of marketing and distribution, along with warehouse and products’ registration.
© 2022 ALL RIGHTS RESREVED
Copyright by BWeinreb Medical Market Access Consulting
